Penn gene therapy spinout taking on rare retinal diseases launches with $19M in seed funding

The company aims to commercialize the research of Penn Medicine gene therapy pioneer Dr. Jean Bennett.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.